PML with dimethyl fumarate-No convincing case against natalizumab

Affiliations

¹ Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.

Comment

Martin Diebold et al. Mult Scler. 2019 Oct.

. 2019 Oct;25(12):1687-1688.

doi: 10.1177/1352458519872894. Epub 2019 Aug 22.

¹ Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.

No abstract available

Comment on

A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.
Diebold M, Altersberger V, Décard BF, Kappos L, Derfuss T, Lorscheider J. Diebold M, et al. Mult Scler. 2019 Oct;25(12):1682-1685. doi: 10.1177/1352458519852100. Epub 2019 Jun 18. Mult Scler. 2019. PMID: 31208265
PML with dimethyl fumarate-No role for natalizumab?
Berger JR. Berger JR. Mult Scler. 2019 Oct;25(12):1686-1687. doi: 10.1177/1352458519872897. Epub 2019 Aug 22. Mult Scler. 2019. PMID: 31436127 No abstract available.